BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20473893)

  • 1. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
    Lurie G; Wilkens LR; Thompson PJ; Carney ME; Palmieri RT; Pharoah PD; Song H; Hogdall E; Kjaer SK; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Goodman MT;
    Int J Cancer; 2011 Feb; 128(4):936-43. PubMed ID: 20473893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.
    Lurie G; Terry KL; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Palmieri RT; Cramer DW; Goodman MT
    Cancer Causes Control; 2010 Oct; 21(10):1731-41. PubMed ID: 20559705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
    Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; deFazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G; ; ;
    PLoS Genet; 2010 Jul; 6(7):e1001016. PubMed ID: 20628624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cataract and ovarian carcinoma: is the vitamin D hypothesis alive?
    Lurie G; Matsuno RK; Wilkens LR; Thompson PJ; Ollberding NJ; Carney ME; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2507-11. PubMed ID: 21976293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study.
    Bentley RW; Keown DA; Gearry RB; Cameron VA; Keenan J; Roberts RL; Day AS
    N Z Med J; 2012 Jun; 125(1356):47-51. PubMed ID: 22729058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis.
    Chen H; Zhu J
    J Obstet Gynaecol Res; 2018 Mar; 44(3):556-565. PubMed ID: 29239065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong Cumulative Evidence of Associations of 6 Single Nucleotide Polymorphisms with Ovarian Cancer Risk: An Umbrella Review.
    Huo YJ; Li XY; Zhang M; Gao C; Xiao Q; Zhao YH; Gao S; Gong TT; Wu QJ
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902812
    [No Abstract]   [Full Text] [Related]  

  • 8. Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D Serum Levels With Prostate Cancer in Kurdish Population in West of Iran.
    Amiri M; Elieh Ali Komi D; Vaisi-Raygani A; Kiani A; Moradi M; Aliyari M; Rahimi Z; Mohammadi-Noori E; Bashiri H
    Pathol Oncol Res; 2022; 28():1610246. PubMed ID: 36017197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis.
    Hu J; Xu Z; Ye Z; Li J; Hao Z; Wang Y
    Cancer Med; 2023 Jan; 12(1):541-556. PubMed ID: 35637613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor gene polymorphisms and uterine fibroid incidence in Caucasian women.
    Ciebiera M; Wrzosek M; Wojtyła C; Zaręba K; Nowicka G; Jakiel G; Włodarczyk M
    Arch Med Sci; 2021; 17(6):1643-1650. PubMed ID: 34900044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Exposure and Ovarian Cancer Risk and Prognosis.
    L'Espérance K; Datta GD; Qureshi S; Koushik A
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32059597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms.
    Dovnik A; Dovnik NF
    Cells; 2020 Feb; 9(2):. PubMed ID: 32024052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing vitamin D for treatment of human malignancies
    Wu X; Hu W; Lu L; Zhao Y; Zhou Y; Xiao Z; Zhang L; Zhang H; Li X; Li W; Wang S; Cho CH; Shen J; Li M
    Acta Pharm Sin B; 2019 Mar; 9(2):203-219. PubMed ID: 30972274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention.
    Guo H; Guo J; Xie W; Yuan L; Sheng X
    J Ovarian Res; 2018 Aug; 11(1):71. PubMed ID: 30157901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.
    Tang L; Li J; Bao M; Xiang J; Chen Y; Wang Y
    Onco Targets Ther; 2018; 11():1055-1066. PubMed ID: 29535531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids.
    Björkhem-Bergman L; Lehtihet M; Rane A; Ekström L
    BMC Res Notes; 2018 Jan; 11(1):51. PubMed ID: 29351807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental genetic variations in vitamin D metabolism and birthweight.
    Workalemahu T; Badon SE; Dishi-Galitzky M; Qiu C; Williams MA; Sorensen T; Enquobahrie DA
    Placenta; 2017 Feb; 50():78-83. PubMed ID: 28161065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of
    Mostowska A; Sajdak S; Pawlik P; Lianeri M; Jagodzinski PP
    Oncol Lett; 2016 Feb; 11(2):1181-1188. PubMed ID: 26893716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression.
    Wang G; Lei L; Zhao X; Zhang J; Zhou M; Nan K
    Oncol Res; 2014; 22(5-6):301-9. PubMed ID: 26629942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis.
    Li S; Xu H; Li SC; Qi XQ; Sun WJ
    Tumour Biol; 2014 Feb; 35(2):1319-22. PubMed ID: 24136742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.